Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction: Still Awaiting Translation

Despite therapeutic advances, acute myocardial infarction (AMI) remains a leading cause of morbidity and mortality worldwide. One potential limitation of the current treatment paradigm is the lack of effective therapies to optimize reperfusion after ischemia and prevent reperfusion-mediated injury....

Descripción completa

Detalles Bibliográficos
Autores principales: Trankle, Cory, Thurber, Clinton J., Toldo, Stefano, Abbate, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
STATE-OF-THE-ART REVIEW
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113419/
https://www.ncbi.nlm.nih.gov/pubmed/30167535
http://dx.doi.org/10.1016/j.jacbts.2016.06.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113419/
https://www.ncbi.nlm.nih.gov/pubmed/30167535
http://dx.doi.org/10.1016/j.jacbts.2016.06.012

Ejemplares similares